Gastric mucosal levels of prostaglandins and leukotrienes in patients with gastric ulcer after treatment with rabeprazole in comparison to treatment with ranitidine

Journal of Medical Investigation

Volumn 54, Issue 1-2, 2007, Pages 83-90

  Okazaki, Michiyo ^a   Shimizu, Ichiro ^b   Ishikawa, Momoko ^c   Fujiwara, Soichiro ^c   Yamamoto, Hirofumi ^c   Shiraishi, Tatsuhiko ^c   Horie, Takahiro ^c   Iuchi, Arata ^c   Ito, Susumu ^b  

^a KOCHI RED CROSS HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c Tokushima Prefectural Miyoshi Hospital   (Japan)

Author keywords

COX 2; H2 blocker; LTB4; PGE2; Rabeprazole

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LEUKOTRIENE; PROSTAGLANDIN; RABEPRAZOLE; RANITIDINE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; 6 OXOPROSTAGLANDIN F1 ALPHA; LEUKOTRIENE B4; MESSENGER RNA; PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HYPERTENSION; MALE; PROTEIN EXPRESSION; STOMACH MUCOSA; STOMACH ULCER; TREATMENT RESPONSE; ULCER HEALING; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; 6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; AGED; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GASTRIC MUCOSA; HUMANS; LEUKOTRIENE B4; MALE; MIDDLE AGED; RANITIDINE; RNA, MESSENGER; STOMACH ULCER;

EID: 34247851037     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.54.83     Document Type: Article

References (33)

1. Sachs G : Proton pump inhibitors and acid-related diseases. Pharmacotherapy 17 : 22-37, 1997
2. Mattsson H, Andersson K, Larsson H : Omeprazole provides protection against experimentally induced gastric mucosal lesions. Eur J Pharmacol 91 : 111-114, 1983
3. Konturek SJ, Brzozowski T, Radecki T : Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion 27 : 159-164, 1983
4. Watanabe T, Higuchi K, Tominaga K, Fujiwara Y, Arakawa T : Cytoprotective effect of rabeprazole against ehtanol-induced gatric mucosal damage: possible involvement of nitric oxide. Drugs Exp Clin Res 26 : 41-45, 2000
5. Tsuji S, Sun WH, Tsujii M, Kawai N, Kimura A, Kakiuchi Y, Yasumaru S, Komori M, Murata H, Sasaki Y, Kawano S, Hori M : Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J Pharmacol Exp Ther 303 : 1301-1308, 2002
6. Smith WL, Garavito RM, DeWitt DL : Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 : 33157-33160, 1996
7. Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ : Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol 245 : G113-G121, 1983
8. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M : Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112 : 387-397, 1997
9. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN : Leukotrienes and lipoxins : structures, biosynthesis, and biological effects. Science 237 : 1171-1176, 1987
10. Serhan CN, Haeggstrom JZ, Leslie CC : Lipid mediator networks in cell signaling : update and impact of cytokines. FASEB J 10 : 1147-1158, 1996
11. Shimizu I, Horie T, Inoue H, Oshima T, Fujimoto M, Ozaki Y, Yamamoto K, Iuchi A Ito S : Penetration by a giant gastric ulcer induced by a nonsteroidal anti-inflammatory drug. Endoscopy 32 : 539-541, 2000
12. Hla T, Neilson K : Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89 : 7384-7388, 1992
13. Miller TA : Protective effects of prostaglandins against gastric mucosal damage : current knowledge and proposed mechanisms. Am J Physiol 245 : G601-G623, 1983
14. Wallace JL, Tigley AW : Review article : new insights into prostaglandins and mucosal defence. Aliment Pharmacol Ther 9 : 227-235, 1995
15. Asako H, Kubes P, Wallace J, Gaginella T, Wolf RE, Granger DN : Indomethacin-induced leukocyte adhesion in mesenteric venules : role of lipoxygenase products. Am J Physiol 262 : G903-G908, 1992
16. Gudis K, Sakamoto C : The role of cyclooxygenase in gastric mucosal protection. Dig Dis Sci 50 (Suppl 1) : S16-S23, 2005
17. Kauffman GL, Zhang L, Xing LP, Seaton J, Colony P, Demers L : Central neurotensin protects the mucosa by a prostaglandin-mediated mechanism and inhibits gastric acid secretion in the rat. Ann NY Acad Sci 597 : 175-190, 1990
18. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ : Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 34 : 748-751, 1993
19. Kim JS, Kim JM, Jung HC, Song IS : Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway. Dig Dis Sci 46 : 2277-2284, 2001
20. 2) in endoscopic polypectomy-induced human ulcers. Gastroenterol Jpn 17 : 430-433, 1982
21. 2 on humna gastric ulcers. Gastroenterol Jpn 17 : 21-24, 1982
22. Peskar BM : Leukotrienes in mucosal damage and protection. J Physiol Pharmacol 42 : 135-145, 1991
23. Pihan G, Rogers C, Szabo S : Vascular injury in acute gastric mucosal damage. Mediatory role of leukotrienes. Dig Dis Sci 33 : 625-632, 1988
24. Takahashi S, Shigeta J, Inoue H, Tanabe T, Okabe S : Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am J Physiol 275 : G1137-G1145, 1998
25. Tatsuguchi A, Sakamoto C, Wada K, Akamatsu T, Tsukui T, Miyake K, Futagami S, Kishida T, Fukuda Y, Yamanaka N, Kobayashi M : Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 46 : 782-789, 2000
26. Shigeta J, Takahashi S, Okabe S : Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J Pharmacol Exp Ther 286 : 1383-1390, 1998
27. Brzozowski T, Konturek PC, Konturek SJ, Schuppan D, Drozdowicz D, Kwiecien S, Majka J, Nakamura T, Hahn E : Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2. Digestion 64 : 15-29, 2001
28. Skoczylas T, Sarosiek I, Sostarich S, McElhinney C, Durham S, Sarosiek J : Significant enhancement of gastric mucin content after rabeprazole administration : its potential clinical significance in acid-related disorders. Dig Dis Sci 48 : 322-328, 2003
29. Wandall JH : Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33 : 617-621, 1992
30. Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, Ishii H : Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 21 : 727-731, 1996
31. Lapenna D, de GS, Ciofani G, Festi D, Cuccurullo F : Antioxidant properties of omeprazole. FEBS Lett 382 : 189-192, 1996
32. Akimoto M, Hashimoto H, Shigemoto M, Maeda A, Yamashita K : Effects of antisecretory agents on angiogenesis during healing of gastric ulcers. J Gastroenterol 40 : 685-689, 2005
33. Tsuji S, Kawano S, Tsujii M, Michida T, Masuda E, Gunawan ES, Hori M : Mucosal microcirculation and angiogenesis in gastrointestinal tract. Jpn J Clin Med 56 : 2247-2252, 1998